Filing Flows › Chemours (CC) › Q1 2025
Chemours (CC) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 6, 2025
Chemours (CC) reported revenue of $1.4B for the first quarter 2025 (Q1 2025), +0.4% from a year earlier and +0.7% from the quarter before. Operating margin was 0.0%, net loss $4.0M (0.3% of revenue).
Chemours, Q1 2025: revenue $1.4B (+0.4% year over year), operating margin 0.0%, net loss $4.0M, operating cash flow −$112M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4B | +0.7% | +0.4% |
| Operating profit | $0 | — | — |
| Net earnings | −$4.0M | — | — |
| Operating cash flow | −$112M | — | — |
What changed
Revenue was $1.4B in Q1 2025, roughly flat year over year and up 1% from the previous quarter. All Segments was the largest line at 99% of revenue. All Segments added $0.01B year over year (up 1%), 150% of the total change. Other Non-Reportable Segment declined 21%.
Gross margin was 17.3%, down 3.6 points from a year earlier. Operating profit was $0K, a 0.0% margin (down 5.1 points year over year). Operating profit fell $0.07B even though revenue rose $0.01B versus a year earlier, so costs grew faster than sales. Operating expenses grew 10% against flat revenue. The fastest-growing cost line was Other operating costs (+76%). The quarter ended with a net loss of $4.0M, narrower than the previous quarter's $0.01B loss.
Operating cash flow was −$0.11B. Non-cash charges added back $0.09B of depreciation and $0.01B of share-based compensation. Working capital and other items used $0.20B. Capital expenditures of $0.08B exceeded it, leaving free cash flow of −$0.20B.
Questions
What was Chemours' revenue in the first quarter 2025?
Chemours (CC) reported revenue of $1.4B for the first quarter 2025 (Q1 2025), +0.4% from a year earlier and +0.7% from the quarter before.
Was Chemours profitable in the first quarter 2025?
Operating profit was $0 (0.0% of revenue) and net loss $4.0M.
Source: Chemours 10-Q on SEC EDGAR.